Bill · H.R. 1497· House(119-HR-1497)
NIH Reform Act
- Introduced
- 2/21/2025
- Last activity
- 2/21/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Chip Roy
- Cosponsors
- - 6 - 0
- Introduced
- In Committee
What this bill would do
The NIH Reform Act proposes to dissolve the National Institute of Allergy and Infectious Diseases. This single entity would be replaced by three separate national research institutes. These new institutes would be the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The bill establishes specific purposes for the new institutes regarding research, training, and health information. It also outlines a transition process where the Director of the National Institutes of Health oversees the new institutes until their individual directors are appointed.
Yes
Does this make health care easier to get in general?+2
The bill reorganizes research institutes to potentially focus more effectively on specialized areas of infectious and immunologic diseases.
Does this put more money into medical research?+2
The bill restructures the NIH to establish distinct research focuses for infectious and immunologic diseases.
Does this make what the government does easier for the public to see?+1
The bill increases Senate oversight by requiring advice and consent for the new institute directors.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Establishment of specialized research institutes: The bill creates the National Institute of Infectious Diseases and the National Institute of Immunologic Diseases to focus on specific areas of health research, training, and information dissemination (Section 2(c)(1), 2(c)(2), and 2(c)(3)).
-
Increased oversight for presidential appointments: The bill adds a requirement that the President's appointments for the directors of these three new institutes must be made with the advice and consent of the Senate (Section 2(b)(1)).
Potential Negative Impacts for People
- Termination of existing leadership: The position of Director of the National Institute of Allergy and Infectious Diseases is terminated upon the enactment of this Act (Section 2(b)(3)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Healthcare
- Improves Healthcare Access+2Increases Research Funding+2
- Governance And Ideology
- Improves Government Transparency+1
- 3/5/2025
- 1 Cosponsor added.
- 2/27/2025
- 1 Cosponsor added.
- 2/21/2025
- Referred to the House Committee on Energy and Commerce.
- 4 Cosponsors added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Josh BrecheenRepublican · Oklahoma
Elijah CraneRepublican · Arizona
Paul GosarRepublican · Arizona
H. GriffithRepublican · Virginia
Andy HarrisRepublican · Maryland
Harriet HagemanRepublican · Wyoming